Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enadenotucirev in metastatic epithelial solid tumours and mCRC
NCT02028442Phase 2Completed
- Sponsor
- Akamis Bio
- Start
- Sep 2012
- Primary completion
- Apr 2016
- Modality
- Oncolytic Viruses
- Countries
- 2
01
Overview
A Phase 2 trial of enadenotucirev in solid tumor, metastatic colorectal cancer (mCRC), bladder cancer, sponsored by Akamis Bio. Started Sep 2012; status: completed.
02
Drugs
enadenotucirev
03
Conditions
solid tumormetastatic colorectal cancer (mCRC)bladder cancer
Beyond the preview
Go deeper on NCT02028442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028442.